Inventor · disambiguated record
Jin-San Yoo
Also filed as: YOO JIN-SAN
12 granted patents·6 pending applications·12 citations·filing 2002–2023
83Inventor score
Top patents by PatentIndex Score
18 records- 0187US10106622B2Human antibody specific to c-Met and preparation method thereofPHARMABCINE INC·Filed 2015·Granted Oct 23, 2018·9 cites·8 claims
- 0272US9150650B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofYOO JIN-SAN·Filed 2007·Granted Oct 6, 2015·2 cites·6 claims
- 0366US9963512B2Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including samePHARMABCINE INC·Filed 2013·Granted May 8, 2018·1 cites·4 claims
- 0466US9249219B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0562US9249220B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0656US2025179192A1Fusion protein comprising modified anti-vegfr2 (kdr) antibody and use thereofPHARMABCINE INC·Filed 2023·Application pending·0 cites
- 0755US10125194B2Dual targeting antibody of novel form, and use thereofYOO JIN SAN·Filed 2009·Granted Nov 13, 2018·0 cites·5 claims
- 0855US2024383989A1Modified anti-vegfr2 (kdr) antibody and use thereofPHARMABCINE INC·Filed 2022·Application pending·0 cites
- 0954US2023265196A1Combination Therapy of a PD-1 Antagonist and an Antagonist for VEGFR-2 for Treating Patients with CancerPHARMABCINE INC·Filed 2021·Application pending·0 cites
- 1050US10155817B2Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including samePHARMABCINE INC·Filed 2018·Granted Dec 18, 2018·0 cites·8 claims
- 1147US10597457B2EGFRvIII antibody and composition comprising samePHARMABCINE INC·Filed 2014·Granted Mar 24, 2020·0 cites·9 claims
- 1245US2022204603A1Anti-ang2 antibody and use thereofPHARMABCINE INC·Filed 2020·Application pending·0 cites
- 1345US2021009695A1Anti-vegfr-2 antibodyPHARMABCINE INC·Filed 2019·Application pending·0 cites
- 1444US12473366B2Anti-TIE2 antibody and use thereofPHARMABCINE INC·Filed 2020·Granted Nov 18, 2025·0 cites·15 claims
- 1543US9562227B2Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5KIM SEMI·Filed 2008·Granted Feb 7, 2017·0 cites·6 claims
- 1641US2003096976A1Humanized antibodies LB-00503 and LB-00506 specific for human 4-1BB and pharmaceutical compositions comprising said humanized antibodiesFiled 2002·Application pending·0 cites
- 1740US11407834B2Anti-PD-L1 antibody and use thereofPHARMABCINE INC·Filed 2018·Granted Aug 9, 2022·0 cites·9 claims
- 1839US11407833B2Anti-VISTA antibody and use thereofPHARMABCINE INC·Filed 2018·Granted Aug 9, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Jin-San Yoo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →